Hearing loss related to platinum-based chemotherapeutics has long been recognized. Nonetheless, the preservation of life has outweighed concerns for ototoxicity.
Cancer continues to be a life-altering diagnosis; however, the prevalence of deaths is declining with medical advances. For this reason, it is important to consider the impact of toxicities/morbidities, such as ototoxicity on the quality of life of cancer survivors.
Pearson et al (2019) performed a systematic review of the influence of hearing loss and tinnitus on quality of life in persons treated with cisplatin. The study group screened over 300 abstracts and identified 11 studies as part of the final review. The majority of the studies were cross-sectional in nature (n =6) (two randomized control trials and one longitudinal study) while the remaining were pilot studies.
The overall results in general suggested that quality of life was indeed impacted by hearing loss and/or tinnitus in cancer patients. However, there were significant shortcomings in the literature; some were opinions based on a hypothetical scenario, many did not consider severity of ototoxicity, and there was lack of standardization in report of quality of life. The eye-opening finding of this meta-analysis was the lack of research on quality of life in persons with hearing loss and tinnitus as a of chemotherapy. As survival rates increase, emphasis on long-term toxicities, such as hearing loss and tinnitus, will become more and more critical to address.
Reference
Pearson et al. (2019) Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review, Int J. Audio, prepub.
Related Posts
Recent Posts
A Virtual Reality System for Delivery of Military-Specific Vestibular Rehabilitation After Mild Traumatic Brain Injury: The Praxis Study Protocol
In an article by Alroumi et al. (2025), treatment of mild traumatic brain injury (mTBI) through the use of virtual reality (VR) system was investigated….
From Capitol Hill to Your Clinic: SPAN July Meeting on Medicaid Cuts
The State Policy Advocacy Network (SPAN) will convene again on July 29 for a critical meeting about Medicaid funding. SPAN brings together nationwide audiologists and…
EHDI Program at Risk
On April 1, President Trump’s administration eliminated the entire branch of the Early Hearing Detection and Intervention (EHDI) program that works with states to analyze…